CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 54 filers reported holding CASI PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |